首页> 外文期刊>Pediatric blood & cancer >Pulmonary Outcomes in Patients with Hodgkin Lymphoma Treated with Involved Field Radiation
【24h】

Pulmonary Outcomes in Patients with Hodgkin Lymphoma Treated with Involved Field Radiation

机译:介入放射治疗霍奇金淋巴瘤患者的肺结局

获取原文
获取原文并翻译 | 示例
           

摘要

Background The prevalence of low bone mineral density (BMD) in adult survivors of childhood acute lymphoblastic leukemia (ALL), and the degree of recovery or decline, are not well elucidated. Procedure Study subjects (age >= 18 years and >= 10 years post-diagnosis) participated in an institutional follow-up protocol and risk-based clinical evaluation based on Children's Oncology Group guidelines. Trabecular volumetric BMD was ascertained using quantitative computed tomography, reported as age- and sex-specific Z-scores. Results At median age 31 years, 5.7% of 845 subjects had a BMD Z-score of <=-2 and 23.8% had a Z-score of -1 to -2. Cranial radiation dose of >= 24 Gy, but not cumulative methotrexate or prednisone equivalence doses, was associated with a twofold elevated risk of a BMD Z-score of <=-1. The cranial radiation effect was stronger in females than in males. In a subset of 400 subjects, 67% of those who previously had a BMD Z-score of <=-2 improved by one or more categories a median of 8.5 years later. Conclusions Very low BMD was relatively uncommon in this sample of adult survivors of childhood ALL, and BMD Z-scores tended to improve from adolescence to young adulthood. High-dose cranial or craniospinal radiation exposure was the primary predictor of suboptimal BMD in our study. Given that cranial radiation treatment for childhood ALL is used far more sparingly now than in earlier treatment eras, concerns about persistently low BMD among most current childhood ALL patients may be unwarranted. Pediatr Blood Cancer 2014;61:1270-1276. (c) 2014 Wiley Periodicals, Inc.
机译:背景尚未充分阐明儿童急性淋巴细胞白血病(ALL)的成年幸存者中低骨密度(BMD)的患病率以及恢复或下降的程度。程序研究对象(年龄≥18岁且诊断后≥10岁)参加了机构随访方案,并根据儿童肿瘤学小组指南进行了基于风险的临床评估。使用定量计算机断层扫描确定小梁体积骨密度,报告为特定年龄和性别的Z评分。结果在中位年龄31岁,845名受试者的5.7%的BMD Z得分<=-2,23.8%的ZMD得分为-1至-2。 ≥24 Gy的颅脑辐射剂量,而非累积的甲氨蝶呤或泼尼松等效剂量,与BMD Z分数<=-1的两倍升高风险相关。女性的颅骨放射作用比男性强。在400名受试者的子集中,以前BMD Z得分<=-2的受试者中有67%在8.5年后中位数提高了一个或多个类别。结论在儿童ALL成年幸存者的样本中,极低的BMD相对少见,并且从青春期到成年期,BMD Z值趋于改善。在我们的研究中,大剂量颅骨或颅骨放射线暴露是次优BMD的主要预测因子。鉴于与早期治疗时代相比,现在用于儿童ALL的颅骨放射治疗要少得多,因此对于当前大多数儿童ALL患者中BMD持续偏低的担忧可能会毫无根据。小儿血液癌2014; 61:1270-1276。 (c)2014年威利期刊有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号